Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides: The First Double-Blind, Randomized, Controlled Trial in Pre-term Infants.

Hascoët, Jean-Michel; Chevallier, Marie; Gire, Catherine; Brat, Roselyne; Rozé, Jean-Christophe; Norbert, Karine; Chen, Yipu; Hartweg, Mickaël; Billeaud, Claude

Hascoët, Jean-Michel; Chevallier, Marie; Gire, Catherine; Brat, Roselyne; Rozé, Jean-Christophe; Norbert, Karine; Chen, Yipu; Hartweg, Mickaël; Billeaud, Claude.

Afiliação

Hascoët JM; Maternite Regionale Universitaire A. Pinard, Nancy, France.
Chevallier M; Hopital Couple Enfant, CHU de Grenoble Alpes, Grenoble, France.
Gire C; Hôpital Nord Chemin des Bourrely, Marseille, France.
Brat R; CHR Orléans, Orléans, France.
Rozé JC; Hôpital Femme Enfant Adolescent Néonatologie et Réanimation Pédiatrique, Nantes, France.
Norbert K; Centre Hospitalier de Pau, Pau, France.
Chen Y; Nestlé Product Technology Center-Nutrition, Vevey, Switzerland.
Hartweg M; Nestlé Clinical Development Unit, Lausanne, Switzerland.
Billeaud C; CHU de Bordeaux CIC, Hôpital des Enfants, Bordeaux, France.

Front Pediatr ; 10: 858380, 2022.

Article em En | MEDLINE | ID: mdl-35601412

Palavras-chave

growth; human milk oligosaccharides (HMOs); nutrition; pre-term; supplement; time to full enteral feeding

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article